Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuzmin, I.
Right arrow Articles by Lerman, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuzmin, I.
Right arrow Articles by Lerman, M. I.
[Cancer Research 62, 3498-3502, June 15, 2002]
© 2002 American Association for Cancer Research


Molecular Biology and Genetics

The RASSF1A Tumor Suppressor Gene Is Inactivated in Prostate Tumors and Suppresses Growth of Prostate Carcinoma Cells1

Igor Kuzmin2, John W. Gillespie, Alexei Protopopov, Laura Geil, Koen Dreijerink, Youfeng Yang, Cathy D. Vocke, Fuh-Mei Duh, Eugene Zabarovsky, John D. Minna, Johng S. Rhim, Michael R. Emmert-Buck, W. Marston Linehan and Michael I. Lerman

Intramural Research Support Program, SAIC-Frederick, Inc. [I. K., L. G., F-M. D.] and Laboratory of Immunobiology [K. D., M. I. L.], National Cancer Institute Frederick, Frederick, Maryland 21702; Laboratory of Pathology [J. W. G., M. R. E-B.] and Urologic Oncology Branch [Y. Y., C. D. V., W. M. L.], National Cancer Institute Bethesda, Bethesda, Maryland 20892; MTC and CGR, The Karolinska Institute, 171 77 Stockholm, Sweden [A. P., E. Z.]; Engelhardt Institute of Molecular Biology, Moscow 117984, Russia [E. Z.]; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390 [J. D. M.]; and Center for Prostate Disease Research, Uniformed Services University of Health Sciences, Bethesda, Maryland, 20814 [J. S. R.]

We analyzed expression status of the recently identified tumor suppressor geneRASSF1A in primary prostate carcinomas and in prostate cell lines. We found complete methylation of the RASSF1A promoter in 63% of primary microdissected prostate carcinomas (7 of 11 samples). The remaining 4 samples (37%) were partially methylated, possibly because of contamination with normal cells. No promoter methylation was observed in matching normal prostate tissues. High levels of RASSF1A transcript and no methylation of RASSF1A promoter were found in explanted primary normal prostate epithelial and stromal cells. Complete silencing and methylation of RASSF1A promoter was observed in five widely used prostate carcinoma cell lines, which acquired the ability to grow in culture spontaneously, including LNCaP, PC-3, ND-1, DU-145, 22Rv1, and one primary prostate carcinoma immortalized by overexpression of the human telomerase catalytic subunit (RC-58T/hTERT). However, no silencing of RASSF1A was found in four other prostate carcinoma cell lines, which were adapted for cell culture after transformation with human papillomaviral DNA. Suppression of cell growth in vitro was demonstrated after the reintroduction of RASSF1A-expressing construct into LNCaP prostate carcinoma cells. Our data implicate the RASSF1A gene in human prostate tumorigenesis.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
H. Donninger, M. D. Vos, and G. J. Clark
The RASSF1A tumor suppressor
J. Cell Sci., September 15, 2007; 120(18): 3163 - 3172.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Kwabi-Addo, W. Chung, L. Shen, M. Ittmann, T. Wheeler, J. Jelinek, and J.-P. J. Issa
Age-Related DNA Methylation Changes in Normal Human Prostate Tissues
Clin. Cancer Res., July 1, 2007; 13(13): 3796 - 3802.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
D. Angeloni
Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease
Brief Funct Genomic Proteomic, May 24, 2007; (2007) elm007v1.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Roupret, V. Hupertan, D. R. Yates, J. W.F. Catto, I. Rehman, M. Meuth, S. Ricci, R. Lacave, G. Cancel-Tassin, A. de la Taille, et al.
Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate Massage
Clin. Cancer Res., March 15, 2007; 13(6): 1720 - 1725.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
J. Geli, N. Kiss, F. Lanner, T. Foukakis, N. Natalishvili, O. Larsson, P. Kogner, A. Hoog, G. J Clark, T. J Ekstrom, et al.
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma
Endocr. Relat. Cancer, March 1, 2007; 14(1): 125 - 134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. G. Amaar, M. G. Minera, L. K. Hatran, D. D. Strong, S. Mohan, and M. E. Reeves
Ras association domain family 1C protein stimulates human lung cancer cell proliferation
Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1185 - L1190.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
A. S Perry, R. Foley, K. Woodson, and M. Lawler
The emerging roles of DNA methylation in the clinical management of prostate cancer.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 357 - 377.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Vos, A. Dallol, K. Eckfeld, N. P. C. Allen, H. Donninger, L. B. Hesson, D. Calvisi, F. Latif, and G. J. Clark
The RASSF1A Tumor Suppressor Activates Bax via MOAP-1
J. Biol. Chem., February 24, 2006; 281(8): 4557 - 4563.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. T. McCabe, J. A. Low, S. Daignault, M. J. Imperiale, K. J. Wojno, and M. L. Day
Inhibition of DNA Methyltransferase Activity Prevents Tumorigenesis in a Mouse Model of Prostate Cancer
Cancer Res., January 1, 2006; 66(1): 385 - 392.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Ni, X. Wen, J. Yao, H.-C. Chang, Y. Yin, M. Zhang, S. Xie, M. Chen, B. Simons, P. Chang, et al.
Tocopherol-Associated Protein Suppresses Prostate Cancer Cell Growth by Inhibition of the Phosphoinositide 3-Kinase Pathway
Cancer Res., November 1, 2005; 65(21): 9807 - 9816.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. O. Hoque, O. Topaloglu, S. Begum, R. Henrique, E. Rosenbaum, W. Van Criekinge, W. H. Westra, and D. Sidransky
Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects
J. Clin. Oncol., September 20, 2005; 23(27): 6569 - 6575.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Dote, D. Cerna, W. E. Burgan, D. J. Carter, M. A. Cerra, M. G. Hollingshead, K. Camphausen, and P. J. Tofilon
Enhancement of In vitro and In vivo Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine
Clin. Cancer Res., June 15, 2005; 11(12): 4571 - 4579.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Lodygin, A. Epanchintsev, A. Menssen, J. Diebold, and H. Hermeking
Functional Epigenomics Identifies Genes Frequently Silenced in Prostate Cancer
Cancer Res., May 15, 2005; 65(10): 4218 - 4227.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Agathanggelou, W. N. Cooper, and F. Latif
Role of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human Cancers
Cancer Res., May 1, 2005; 65(9): 3497 - 3508.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Song, J. S. Chang, S. J. Song, T. H. Yang, H. Lee, and D.-S. Lim
The Centrosomal Protein RAS Association Domain Family Protein 1A (RASSF1A)-binding Protein 1 Regulates Mitotic Progression by Recruiting RASSF1A to Spindle Poles
J. Biol. Chem., February 4, 2005; 280(5): 3920 - 3927.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L.-C. Li, P. R. Carroll, and R. Dahiya
Epigenetic Changes in Prostate Cancer: Implication for Diagnosis and Treatment
J Natl Cancer Inst, January 19, 2005; 97(2): 103 - 115.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Tommasi, R. Dammann, Z. Zhang, Y. Wang, L. Liu, W. M. Tsark, S. P. Wilczynski, J. Li, M. You, and G. P. Pfeifer
Tumor Susceptibility of Rassf1a Knockout Mice
Cancer Res., January 1, 2005; 65(1): 92 - 98.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Jeronimo, R. Henrique, M. O. Hoque, E. Mambo, F. R. Ribeiro, G. Varzim, J. Oliveira, M. R. Teixeira, C. Lopes, and D. Sidransky
A Quantitative Promoter Methylation Profile of Prostate Cancer
Clin. Cancer Res., December 15, 2004; 10(24): 8472 - 8478.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Dallol, A. Agathanggelou, S. L. Fenton, J. Ahmed-Choudhury, L. Hesson, M. D. Vos, G. J. Clark, J. Downward, E. R. Maher, and F. Latif
RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics
Cancer Res., June 15, 2004; 64(12): 4112 - 4116.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. D Vos, A. Martinez, C. Elam, A. Dallol, B. J Taylor, F. Latif, and G. J Clark
A Role for the RASSF1A Tumor Suppressor in the Regulation of Tubulin Polymerization and Genomic Stability
Cancer Res., June 15, 2004; 64(12): 4244 - 4250.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. H. N. Wong, J. Chan, J. Wong, and P. K. H. Tam
Ubiquitous Aberrant RASSF1A Promoter Methylation in Childhood Neoplasia1
Clin. Cancer Res., February 1, 2004; 10(3): 994 - 1002.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Fenton, A. Dallol, A. Agathanggelou, L. Hesson, J. Ahmed-Choudhury, S. Baksh, C. Sardet, R. Dammann, J. D. Minna, J. Downward, et al.
Identification of the E1A-Regulated Transcription Factor p120E4F as an Interacting Partner of the RASSF1A Candidate Tumor Suppressor Gene
Cancer Res., January 1, 2004; 64(1): 102 - 107.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D.-H. Kim, J. S. Kim, J.-H. Park, S. K. Lee, Y.-I. Ji, Y. M. Kwon, Y. M. Shim, J. Han, and J. Park
Relationship of Ras Association Domain Family 1 Methylation and K-Ras Mutation in Primary Non-Small Cell Lung Cancer
Cancer Res., October 1, 2003; 63(19): 6206 - 6211.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Agathanggelou, I. Bieche, J. Ahmed-Choudhury, B. Nicke, R. Dammann, S. Baksh, B. Gao, J. D. Minna, J. Downward, E. R. Maher, et al.
Identification of Novel Gene Expression Targets for the Ras Association Domain Family 1 (RASSF1A) Tumor Suppressor Gene in Non-Small Cell Lung Cancer and Neuroblastoma
Cancer Res., September 1, 2003; 63(17): 5344 - 5351.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
W.A. Schulz, M. Burchardt, and M.V. Cronauer
Molecular biology of prostate cancer
Mol. Hum. Reprod., August 1, 2003; 9(8): 437 - 448.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Cohen, G. Singer, O. Lavie, S. M. Dong, U. Beller, and D. Sidransky
The RASSF1A Tumor Suppressor Gene Is Commonly Inactivated in Adenocarcinoma of the Uterine Cervix
Clin. Cancer Res., August 1, 2003; 9(8): 2981 - 2984.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Kuzmin, L. Liu, R. Dammann, L. Geil, E. J. Stanbridge, S. P. Wilczynski, M. I. Lerman, and G. P. Pfeifer
Inactivation of RAS Association Domain Family 1A Gene in Cervical Carcinomas and the Role of Human Papillomavirus Infection
Cancer Res., April 15, 2003; 63(8): 1888 - 1893.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Spugnardi, S. Tommasi, R. Dammann, G. P. Pfeifer, and D. S. B. Hoon
Epigenetic Inactivation of RAS Association Domain Family Protein 1 (RASSF1A) in Malignant Cutaneous Melanoma
Cancer Res., April 1, 2003; 63(7): 1639 - 1643.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.